Bank of Montreal
RYTM icon

Bank of Montreal’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bank of Montreal’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38,000
Closed -$3.84M – 3803
2025
Q3 		$3.84M Buy
+38,000
New +$3.53M ﹤0.01% 1412
2022
Q4 		– Sell
-30,000
Closed -$747K – 4245
2022
Q3 		$747K Buy
+30,000
New +$558K ﹤0.01% 2339

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of Montreal's RYTM Position: Q2 2026 in Review

Bank of Montreal sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 3,801 shares — an estimated $331K sold.

Bank of Montreal first reported a position in RYTM in Q2 2018 and held it in 15 quarters. The position peaked at $3.09M in Q2 2021. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Bank of Montreal reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Bank of Montreal sold 3,801 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $331K.
  • Bank of Montreal first reported a position in Rhythm Pharmaceuticals in Q2 2018 and held it in 15 quarters.
  • Bank of Montreal's Rhythm Pharmaceuticals position peaked at $3.09M in Q2 2021.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.